Abstract
The expansion of colorectal cancer screening programs predicts a remarkable increase
in rectal cancer diagnosis and nonmalignant polyps. While most polyps are managed
endoscopically, many patients are referred to surgery. Over 30 thousand patients with
colon polyps undergo surgical resection annually in the United States. Most of these
surgical resections typically report benign pathology but end up with organ loss.
Such organ resections may enclose significant morbidity and mortality rates. On the
other hand, advanced endoscopic interventions have significantly evolved and are gaining
popularity due to claiming organ preservation with low morbidity and mortality. These
procedures have the potential to develop further and, in no doubt, are becoming standard
of care. There are recent articles reporting successful and feasible initial incorporation
of robotic systems for submucosal dissection procedures. These developments confirm
that endorobotic submucosal dissection and endorobotic surgery may soon become a reality
for colorectal lesions. This article aims to discuss endoluminal surgery for colorectal
lesions and future directions.
Keywords
endoluminal surgery - advanced endoscopy - endorobotic submucosal dissection
